LoA Update: AMO Pharma’s AMO-1 for PMS and epilepsy sees 13-point leap in regulatory …,

… received a single, 6-hour intravenous infusion of AMO-01 at the onset of the study, totalling 120 mg/m2 of treatment, according to Clinical Trials.gov., … received a single, 6-hour intravenous infusion of AMO-01 at the onset of the study, totalling 120 mg/m2 of treatment, according to Clinical Trials.gov., Read More

Scroll to Top